Yüklüyor......
One Small Step for Empagliflozin, One Giant Leap for Diabetology
This article discusses the recently published EMPA-REG OUTCOME trial, which assessed cardiovascular outcomes with empagliflozin therapy in persons with type 2 diabetes mellitus and coexisting cardiovascular disease. The article describes the background and challenges of modern cardiovascular outcome...
Kaydedildi:
| Yayımlandı: | Diabetes Ther |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer Healthcare
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4674475/ https://ncbi.nlm.nih.gov/pubmed/26537704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-015-0144-9 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|